Productos

Búsqueda de productos

Búsqueda global

Para reportar un evento adverso o por cualquier inquietud sobre temas de seguridad de nuestros medicamentos

haga click aquí
Laboratorios Bagó Exibral

Exibral

Forma farmacéutica

Comprimidos Recubiertos

Composición

Cada Comprimido Recubierto contiene:
Divalproato Sódico (equivalente a 500 mg de Ácido Valproico) 538,1 mg

Acción terapéutica

Antiepiléptico.

Indicaciones

Ver Prospecto

Presentaciones

Envases conteniendo 50 Comprimidos Recubiertos.

 

 

Médicos 
Array
(
    [ID] => 11550
    [post_author] => 16
    [post_date] => 2015-08-04 13:44:10
    [post_date_gmt] => 2015-08-04 16:44:10
    [post_content] => 
Forma farmacéutica

Comprimidos Recubiertos

Composición

Cada Comprimido Recubierto contiene:
Divalproato Sódico (equivalente a 500 mg de Ácido Valproico) 538,1 mg

Acción terapéutica

Antiepiléptico.

Indicaciones

Ver Prospecto

Presentaciones

Envases conteniendo 50 Comprimidos Recubiertos.

 

 
    [post_title] => Exibral
    [post_excerpt] => Anticonvulsivante.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => exibral-250-500
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2025-03-20 09:03:02
    [post_modified_gmt] => 2025-03-20 12:03:02
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=11550
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19915
                    [post_author] => 16
                    [post_date] => 2025-03-20 09:02:18
                    [post_date_gmt] => 2025-03-20 12:02:18
                    [post_content] => 
                    [post_title] => EXIBRAL CoR Información p paciente Disp. 1620-25
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => exibral-cor-informacion-p-paciente-disp-1620-25
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-03-20 09:02:18
                    [post_modified_gmt] => 2025-03-20 12:02:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2025/03/EXIBRAL-CoR-Informacion-p-paciente-Disp.-1620-25.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19914
                    [post_author] => 16
                    [post_date] => 2025-03-20 09:02:17
                    [post_date_gmt] => 2025-03-20 12:02:17
                    [post_content] => 
                    [post_title] => EXIBRAL CoR Prospecto Disp. 1620-25
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => exibral-cor-prospecto-disp-1620-25
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-03-20 09:02:17
                    [post_modified_gmt] => 2025-03-20 12:02:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2025/03/EXIBRAL-CoR-Prospecto-Disp.-1620-25.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19705
                    [post_author] => 16
                    [post_date] => 2024-10-28 10:23:07
                    [post_date_gmt] => 2024-10-28 13:23:07
                    [post_content] => 
                    [post_title] => exibral bago-imagen
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => exibral-bago-imagen
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-28 10:23:07
                    [post_modified_gmt] => 2024-10-28 13:23:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/10/exibral-bago-imagen.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Exibral
        )

    [principio_activo] => Array
        (
            [0] => Divalproato Sódico
        )

    [post_content_formatted] => 
Forma farmacéutica


Comprimidos Recubiertos


Composición


Cada Comprimido Recubierto contiene:

Divalproato Sódico (equivalente a 500 mg de Ácido Valproico) 538,1 mg


Acción terapéutica


Antiepiléptico.


Indicaciones


Ver Prospecto


Presentaciones


Envases conteniendo 50 Comprimidos Recubiertos.


 


 


)

Información del producto: Exibral

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/EXIBRAL-CoR-Prospecto-Disp.-1620-25.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:501617;}
        )

)
Ver Prospecto > 
Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2025/03/EXIBRAL-CoR-Informacion-p-paciente-Disp.-1620-25.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:355743;}
        )

)
Ver Información para Pacientes

Bibliografía de Exibral

Ver todos > 
anexo_congre_single

ADVERTENCIA:

El material incluido en este sitio ha sido concebido exclusivamente para los profesionales de la salud con fines informativos, y destinado a orientar sobre el uso adecuado de los medicamentos y a satisfacer sus necesidades de mayor información.

Todos los textos referidos a nuestros productos de venta bajo prescripción médica se corresponden a los lineamientos aprobados por la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT).

Laboratorios Bagó le sugiere consultar siempre a un profesional de la salud calificado ante cualquier duda sobre una condición médica particular.

He comprendido y deseo ver la información

Consultas médicas: infoproducto@bago.com.ar